Afzal B. Shaik

1.7k total citations · 1 hit paper
60 papers, 1.3k citations indexed

About

Afzal B. Shaik is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Afzal B. Shaik has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Organic Chemistry, 22 papers in Molecular Biology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Afzal B. Shaik's work include Synthesis and biological activity (42 papers), Synthesis and Biological Evaluation (17 papers) and Synthesis and Characterization of Heterocyclic Compounds (13 papers). Afzal B. Shaik is often cited by papers focused on Synthesis and biological activity (42 papers), Synthesis and Biological Evaluation (17 papers) and Synthesis and Characterization of Heterocyclic Compounds (13 papers). Afzal B. Shaik collaborates with scholars based in India, United Arab Emirates and Malaysia. Afzal B. Shaik's co-authors include Richie R. Bhandare, Dilep Kumar Sigalapalli, Y. Rajendra Prasad, Suraj N. Mali, Rameshwari Verma, Kothanahally S. Sharath Kumar, Kanchugarakoppal S. Rangappa, Santosh Kumar Verma, K.P. Rakesh and Sathish Kumar Konidala and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Afzal B. Shaik

55 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective

2022 168 citations Dilep Kumar Sigalapalli, Richie R. Bhandare et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Afzal B. Shaik India	20	897	355	211	104	72	60	1.3k
Richie R. Bhandare United Arab Emirates	21	750 0.8×	314 0.9×	188 0.9×	106 1.0×	60 0.8×	59	1.2k
Rashad Al‐Salahi Saudi Arabia	22	982 1.1×	415 1.2×	95 0.5×	76 0.7×	89 1.2×	150	1.5k
Mohammed Mahbubul Matin Bangladesh	18	749 0.8×	450 1.3×	221 1.0×	98 0.9×	44 0.6×	74	1.1k
Ravindar Lekkala China	18	1.4k 1.6×	430 1.2×	81 0.4×	95 0.9×	62 0.9×	23	1.7k
Mohammed Al‐Ghorbani Saudi Arabia	18	492 0.5×	207 0.6×	117 0.6×	83 0.8×	61 0.8×	60	780
Lotfollah Saghaie Iran	20	512 0.6×	333 0.9×	269 1.3×	64 0.6×	102 1.4×	71	1.1k
Swastika Ganguly India	20	1.1k 1.3×	424 1.2×	170 0.8×	100 1.0×	173 2.4×	87	1.6k
Manikandan Anandhan India	22	728 0.8×	366 1.0×	245 1.2×	142 1.4×	86 1.2×	88	1.4k
Sanjiv Kumar India	19	857 1.0×	284 0.8×	150 0.7×	74 0.7×	91 1.3×	35	1.2k
Akranth Marella India	13	1.0k 1.1×	310 0.9×	133 0.6×	141 1.4×	129 1.8×	21	1.3k

Countries citing papers authored by Afzal B. Shaik

Since Specialization

Citations

This map shows the geographic impact of Afzal B. Shaik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afzal B. Shaik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afzal B. Shaik more than expected).

Fields of papers citing papers by Afzal B. Shaik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afzal B. Shaik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afzal B. Shaik. The network helps show where Afzal B. Shaik may publish in the future.

Co-authorship network of co-authors of Afzal B. Shaik

This figure shows the co-authorship network connecting the top 25 collaborators of Afzal B. Shaik. A scholar is included among the top collaborators of Afzal B. Shaik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afzal B. Shaik. Afzal B. Shaik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumar, Shubham, et al.. (2025). PI3Kα inhibitors: structural advances, synthesis strategies, and anticancer potential. Journal of Saudi Chemical Society. 29(6).

Thorat, Bapu R., Suraj N. Mali, Umang Shah, et al.. (2025). Hydrazide-Hydrazone Derivatives and Their Antitubercular Activity. Russian Journal of Bioorganic Chemistry. 51(1). 35–52. 3 indexed citations

Sigalapalli, Dilep Kumar, et al.. (2025). Computational Elucidation of Human β-Defensin-2 as a Dual Inhibitor of MMP-9 and PKC-βII for Diabetic Wound Management. ACS Omega. 10(4). 3575–3584.

Keshari, Amit K., et al.. (2025). Discovery of Novel Multiangiogenic Agents Targeting VEGFR2, EphB4, FGFR-1, and TIE-2: Receptor-Based Pharmacophore Modeling, Virtual Screening, and Molecular Modeling Studies. ACS Omega. 10(14). 13880–13897.

Rani, Poonam, et al.. (2024). Designing novel anti-plasmodial quinoline–furanone hybrids: computational insights, synthesis, and biological evaluation targeting Plasmodium falciparum lactate dehydrogenase. RSC Advances. 14(26). 18764–18776. 2 indexed citations

Mali, Suraj N., et al.. (2024). Synthesis, molecular docking and pharmacological evaluations of novel naphthalene-pyrazoline hybrids as new orally active anti-inflammatory agents. Chemical Physics Impact. 8. 100500–100500. 6 indexed citations

Ashames, Akram, et al.. (2023). Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance. RSC Advances. 13(17). 11368–11384. 7 indexed citations

Bhandare, Richie R., et al.. (2023). In Silico Studies, Design and Synthesis of Novel Fused Pyrimidine Derivatives as a DNA Gyrase Inhibitor and Antibacterial Activity Against Quinolone Resistant Escherichia Coli. Journal of Computational Biophysics and Chemistry. 22(6). 687–710. 5 indexed citations

Ferreira, Oberdan Oliveira, Suraj N. Mali, Samir Chtita, et al.. (2023). Synthesis, In-Silico, In Vitro and DFT Assessments of Substituted Imidazopyridine Derivatives as Potential Antimalarials Targeting Hemoglobin Degradation Pathway. Journal of Computational Biophysics and Chemistry. 22(7). 795–814. 9 indexed citations

10.

Daouı, Ossama, Souad Elkhattabi, Mohamed Bakhouch, et al.. (2023). Cyclohexane-1,3-dione Derivatives as Future Therapeutic Agents for NSCLC: QSAR Modeling, In Silico ADME-Tox Properties, and Structure-Based Drug Designing Approach. ACS Omega. 8(4). 4294–4319. 28 indexed citations

11.

Bhandare, Richie R., et al.. (2022). Antitubercular activity assessment of fluorinated chalcones, 2-aminopyridine-3-carbonitrile and 2-amino-4H-pyran-3-carbonitrile derivatives: In vitro, molecular docking and in-silico drug likeliness studies. PLoS ONE. 17(6). e0265068–e0265068. 23 indexed citations

12.

Elmaaty, Ayman Abo, Khaled M. Darwish, Amani Chrouda, et al.. (2021). In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity. ACS Omega. 7(1). 875–899. 73 indexed citations

13.

Verma, Santosh Kumar, Rameshwari Verma, Yarabahally R. Girish, et al.. (2021). Heterogeneous graphitic carbon nitrides in visible-light-initiated organic transformations. Green Chemistry. 24(2). 438–479. 83 indexed citations

14.

Bhandare, Richie R., et al.. (2021). 2D-Quantitative structure activity relationship (QSAR) modeling, docking studies, synthesis and in-vitro evaluation of 1,3,4-thiadiazole tethered coumarin derivatives as antiproliferative agents. Journal of Saudi Chemical Society. 25(7). 101279–101279. 13 indexed citations

15.

Shaik, Afzal B., et al.. (2020). Antimicrobial and antitubercular evaluation of some new 5-amino-1,3,4-thiadiazole-2-thiol derived Schiff bases. Revue Roumaine de Chimie. 65(9). 771–776. 6 indexed citations

16.

Shaik, Afzal B., et al.. (2019). Synthesis and screening of novel lipophilic diarylpropeones as prospective antitubercular, antibacterial and antifungal agents. Biointerface Research in Applied Chemistry. 9(3). 3912–3918. 16 indexed citations

17.

Shaik, Afzal B., et al.. (2019). Synthesis, characterization and antitubercular evaluation of some new isoxazole appended 1-carboxamido-4,5-dihydro-1H-pyrazoles. Journal of Research in Pharmacy. 23(2). 156–163. 17 indexed citations

18.

Shaik, Afzal B., et al.. (2018). (E)-1-(2′,4′-Dimethyl)-(5-acetylthiazole)-(2,4″-difluorophenyl)-prop-2-en-1-one. Molbank. 2018(3). M1019–M1019. 2 indexed citations

19.

Shaik, Afzal B., et al.. (2016). DESIGN, FACILE SYNTHESIS, AND BIOLOGICAL EVALUATION OF NOVEL 1,3-THIAZINE DERIVATIVES AS POTENTIAL ANTICONVULSANT AGENTS. Asian Journal of Pharmaceutical and Clinical Research. 9(5). 272–272. 9 indexed citations

20.

Shaik, Afzal B., et al.. (2014). Synthesis, characterization and biological evaluation of 3,4-dihydropyrimidin-2(1H)-thione derivatives. Archives of applied science research. 6(6). 121–127. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact